Histamine H3 receptor: an emerging target for cancer therapy?
Saved in:
| Title: | Histamine H |
|---|---|
| Authors: | Lauretta P; Laboratory of Tumor Biology and Inflammation. Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA), and the National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina., Martinez Vivot R; Laboratory of Tumor Biology and Inflammation. Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA), and the National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina., Velazco A; Laboratory of Tumor Biology and Inflammation. Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA), and the National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina., Medina VA; Laboratory of Tumor Biology and Inflammation. Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA), and the National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina. vanina_medina@uca.edu.ar. |
| Source: | Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2025 Jun 30; Vol. 74 (1), pp. 97. Date of Electronic Publication: 2025 Jun 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9508160 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-908X (Electronic) Linking ISSN: 10233830 NLM ISO Abbreviation: Inflamm Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
